Abstract
The ongoing COVID-19 mass testing and vaccination campaigns are the result of unprecedented financial investments, rapid research and development, collaborative science, and innovation in delivery systems. It would be a shame to not leverage these systems for other priorities in global health.
Highlights
The ongoing COVID-19 mass testing and vaccination campaigns are the result of unprecedented financial investments, rapid research and development, colla borative science, and innovation in delivery systems
COVID-19 and tuberculosis pose a deadly, dual threat—a syndemic that feeds on social inequities and poverty.[1]
Given the massive setback to progress in reaching tuberculosis targets, it is crucial to leverage COVID-19 innovations and systems to improve tuberculosis care and control
Summary
The ongoing COVID-19 mass testing and vaccination campaigns are the result of unprecedented financial investments, rapid research and development, colla borative science, and innovation in delivery systems. Given the massive setback to progress in reaching tuberculosis targets, it is crucial to leverage COVID-19 innovations and systems to improve tuberculosis care and control. We see many opportunities to use the lessons of COVID-19 to reimagine tuberculosis diagnosis.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
